Clinical Trial Update: Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and immune response of a meningitis vaccine in HIV-infected children and youth completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Meningitis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Meningitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-12